Skip to main content
Clinical Trials/KCT0001037
KCT0001037Completed未知

A double-blind, randomized, parallel, placebo controlled, multi-center phase I/II clinical trial to investigate the safety, tolerability and efficacy of YH14618 following single intradiscal injection in patients with degenerative disc disease

Yuhan0 sites48 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Yuhan
Enrollment
48

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional Study

Eligibility Criteria

Ages
20(Year) to o Limit (—)
Sex
All

Inclusion Criteria

  • 1)Degenerative disc disease patients of aged over 20 years
  • 2)Appropriate for the study by physical examination, laboratory tests, interview
  • 3)Have one or more of the symptomatic lumbar level(L1~S1) as confirmed using radiology(X-ray, MRI and/or discogram/CT)
  • 4)Have signed a written informed consent voluntarily, prior to the any procedure

Exclusion Criteria

  • 1)Subjects unable to have radiological examination
  • 2)Have history of neurological disease
  • 3)Sacroiliac joint dysfunction
  • 4)Have been treated with any drugs for pain control within 7 days prior to the first administration
  • 5)Pregnant women, nursing mothers or subjects who do not agree to assigned contraception in the study
  • 6)Participated in any other clinical trials within 30 days prior to the first administration
  • 7)Other clinically significant disgnosis not to include by investigator

Investigators

Sponsor
Yuhan

Similar Trials